One molecular mechanism implicated in the pathogenesis of NAFLD is an impairment of the function of the farnesoid X receptor (FXR) [11], which is primarily activated by bile acids (BAs) in the liver and gut (Figure 1). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.